MedImpact Healthcare Systems, Inc., the largest independent provider of health solutions, technology, and pharmacy benefit services in the U.S., announced today the expansion of access to Humira biosimilars—Simlandi and adalimumab-adaz—for new patients needing treatment for inflammatory conditions like Crohn’s disease…
Avanzanite Bioscience BV, a specialty pharmaceutical company in the development stage, has announced that the European Commission (EC) has granted marketing authorization for AKANTIOR® (polihexanide), a treatment for acanthamoeba keratitis (AK) in adults and children aged 12 and older. This…
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the European Commission (EC) has granted approval for Ordspono™ (odronextamab) to treat adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL) who have undergone…
Bristol Myers Squibb (NYSE: BMY) has announced that it will present research findings from its comprehensive cardiovascular portfolio at the European Society of Cardiology (ESC) Congress, scheduled for August 30 – September 2, 2024, in London, England. The presentations will…
ADVI Health is excited to announce its acquisition of Partnership for Health Analytic Research (PHAR), a leading consultancy specializing in global health technology assessment (HTA) and health economics and outcomes research (HEOR). Known for delivering impactful, data-driven insights to major…
In 2017, Maria Morais began experiencing severe abdominal pain, which led to gall bladder surgery. However, when the procedure failed to alleviate her discomfort, follow-up tests revealed alarmingly high liver enzyme levels. As a registered nurse, Maria recognized that something…
Aetna Better Health® of Illinois, a CVS Health® company (NYSE: CVS), has announced a generous community investment of $100,000 to the Safer Foundation. This funding aims to assist in housing unhoused families in Chicago. To date, Aetna’s investment has enabled…
Eisai Co., Ltd. (Tokyo, CEO: Haruo Naito) and Biogen Inc. (Cambridge, Massachusetts, CEO: Christopher A. Viehbacher) have announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain has granted Marketing Authorization for their humanized amyloid-beta (Aβ) monoclonal…
Moderna, Inc. (NASDAQ) has announced that the European Commission (EC) has granted marketing authorization for mRESVIA® (mRNA-1345), an mRNA vaccine designed to protect adults aged 60 and older from lower respiratory tract disease caused by RSV (respiratory syncytial virus). This…
Astellas Pharma Inc. (TSE: 4503), led by President and CEO Naoki Okamura, has announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has granted approval for PADCEV™ (enfortumab vedotin). This approval allows the use…
Genmab A/S (Nasdaq: GMAB) has announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) who have undergone two or more lines…
Lupin Limited, a leading global pharmaceutical company, has announced that it has received approval from Health Canada for its biosimilar Pegfilgrastim. The product, to be marketed under the brand name Armlupeg®, will be manufactured at Lupin’s Biotech facility in Pune,…